Global and Japan Pneumonia Vaccine Market Insights, Forecast to 2027

Global and Japan Pneumonia Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Pneumonia Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pneumonia Vaccine Market Size Growth Rate by Type
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Pneumonia Vaccine Market Size Growth Rate by Application
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pneumonia Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Pneumonia Vaccine Revenue 2016-2027
2.1.2 Global Pneumonia Vaccine Sales 2016-2027
2.2 Global Pneumonia Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pneumonia Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Pneumonia Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pneumonia Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pneumonia Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pneumonia Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Pneumonia Vaccine Revenue Forecast by Region (2022-2027)
3 Global Pneumonia Vaccine Competitor Landscape by Players
3.1 Global Top Pneumonia Vaccine Manufacturers by Sales
3.1.1 Global Pneumonia Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Pneumonia Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pneumonia Vaccine Manufacturers by Revenue
3.2.1 Key Pneumonia Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pneumonia Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Pneumonia Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pneumonia Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pneumonia Vaccine Revenue in 2020
3.2.6 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pneumonia Vaccine Price by Manufacturers
3.4 Global Pneumonia Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumonia Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumonia Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Pneumonia Vaccine Market Size by Type (2016-2021)
4.1.1 Global Pneumonia Vaccine Sales by Type (2016-2021)
4.1.2 Global Pneumonia Vaccine Revenue by Type (2016-2021)
4.1.3 Pneumonia Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pneumonia Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Pneumonia Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Pneumonia Vaccine Market Size by Application (2016-2021)
5.1.1 Global Pneumonia Vaccine Sales by Application (2016-2021)
5.1.2 Global Pneumonia Vaccine Revenue by Application (2016-2021)
5.1.3 Pneumonia Vaccine Price by Application (2016-2021)
5.2 Pneumonia Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Pneumonia Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Pneumonia Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Pneumonia Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Pneumonia Vaccine Market Share in Global Market 2016-2027
6.2 Japan Pneumonia Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Pneumonia Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Pneumonia Vaccine Players by Revenue (2016-2021)
6.3 Japan Pneumonia Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Pneumonia Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Pneumonia Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Pneumonia Vaccine Price by Type (2016-2021)
6.4 Japan Pneumonia Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Pneumonia Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Pneumonia Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Pneumonia Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Pneumonia Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Pneumonia Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Pneumonia Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Pneumonia Vaccine Price by Application (2016-2021)
6.6 Japan Pneumonia Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Pneumonia Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Pneumonia Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Pneumonia Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Pneumonia Vaccine Market Size YoY Growth 2016-2027
7.2 North America Pneumonia Vaccine Market Facts & Figures by Country
7.2.1 North America Pneumonia Vaccine Sales by Country (2016-2021)
7.2.2 North America Pneumonia Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Pneumonia Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Pneumonia Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Pneumonia Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Pneumonia Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Pneumonia Vaccine Market Facts & Figures by Country
9.2.1 Europe Pneumonia Vaccine Sales by Country (2016-2021)
9.2.2 Europe Pneumonia Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Pneumonia Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Pneumonia Vaccine Market Facts & Figures by Country
10.2.1 Latin America Pneumonia Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Pneumonia Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pneumonia Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Pneumonia Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pneumonia Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Corporation Information
12.1.2 Pfizer Inc. Description and Business Overview
12.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Glaxosmithkline Plc.
12.2.1 Glaxosmithkline Plc. Corporation Information
12.2.2 Glaxosmithkline Plc. Description and Business Overview
12.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
12.2.5 Glaxosmithkline Plc. Recent Development
12.3 Merck & Co., Inc.
12.3.1 Merck & Co., Inc. Corporation Information
12.3.2 Merck & Co., Inc. Description and Business Overview
12.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
12.3.5 Merck & Co., Inc. Recent Development
12.4 Sanofi Pasteur
12.4.1 Sanofi Pasteur Corporation Information
12.4.2 Sanofi Pasteur Description and Business Overview
12.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
12.4.5 Sanofi Pasteur Recent Development
12.5 Serum Institute of India Pvt. Ltd.
12.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
12.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
12.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
12.5.5 Serum Institute of India Pvt. Ltd. Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Astellas Pharma Inc.
12.7.1 Astellas Pharma Inc. Corporation Information
12.7.2 Astellas Pharma Inc. Description and Business Overview
12.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
12.7.5 Astellas Pharma Inc. Recent Development
12.8 Astrazeneca Plc.
12.8.1 Astrazeneca Plc. Corporation Information
12.8.2 Astrazeneca Plc. Description and Business Overview
12.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
12.8.5 Astrazeneca Plc. Recent Development
12.9 CSL Limited
12.9.1 CSL Limited Corporation Information
12.9.2 CSL Limited Description and Business Overview
12.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 CSL Limited Pneumonia Vaccine Products Offered
12.9.5 CSL Limited Recent Development
12.10 Emergent Biosolutions
12.10.1 Emergent Biosolutions Corporation Information
12.10.2 Emergent Biosolutions Description and Business Overview
12.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
12.10.5 Emergent Biosolutions Recent Development
12.11 Pfizer Inc.
12.11.1 Pfizer Inc. Corporation Information
12.11.2 Pfizer Inc. Description and Business Overview
12.11.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Inc. Pneumonia Vaccine Products Offered
12.11.5 Pfizer Inc. Recent Development
12.12 Royal (Wuxi) Bio-Pharmaceutical
12.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
12.12.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
12.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Royal (Wuxi) Bio-Pharmaceutical Products Offered
12.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
12.13 Zhifei Biologic
12.13.1 Zhifei Biologic Corporation Information
12.13.2 Zhifei Biologic Description and Business Overview
12.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Zhifei Biologic Products Offered
12.13.5 Zhifei Biologic Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pneumonia Vaccine Industry Trends
13.2 Pneumonia Vaccine Market Drivers
13.3 Pneumonia Vaccine Market Challenges
13.4 Pneumonia Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumonia Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Pneumonia Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Pneumococcal Conjugate Vaccine (PCV13)
Table 3. Major Manufacturers of Pneumococcal Polysaccharide Vaccine (PPSV23)
Table 4. Major Manufacturers of Other
Table 5. Global Pneumonia Vaccine Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 6. Global Pneumonia Vaccine Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Pneumonia Vaccine Sales by Regions (2016-2021) & (K Doses)
Table 8. Global Pneumonia Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Pneumonia Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Pneumonia Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 11. Global Pneumonia Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Pneumonia Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Pneumonia Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Pneumonia Vaccine Sales by Manufacturers (2016-2021) (K Doses)
Table 15. Global Pneumonia Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Pneumonia Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Pneumonia Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Pneumonia Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Vaccine as of 2020)
Table 21. Key Manufacturers Pneumonia Vaccine Price (2016-2021) (USD/Dose)
Table 22. Pneumonia Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pneumonia Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Pneumonia Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumonia Vaccine Sales by Type (2016-2021) (K Doses)
Table 27. Global Pneumonia Vaccine Sales Share by Type (2016-2021)
Table 28. Global Pneumonia Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Pneumonia Vaccine Revenue Share by Type (2016-2021)
Table 30. Pneumonia Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 31. Global Pneumonia Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 32. Global Pneumonia Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Pneumonia Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Pneumonia Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Pneumonia Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 36. Global Pneumonia Vaccine Sales by Application (2016-2021) (K Doses)
Table 37. Global Pneumonia Vaccine Sales Share by Application (2016-2021)
Table 38. Global Pneumonia Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Pneumonia Vaccine Revenue Share by Application (2016-2021)
Table 40. Pneumonia Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 41. Global Pneumonia Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 42. Global Pneumonia Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Pneumonia Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Pneumonia Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Pneumonia Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 46. Japan Pneumonia Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 47. Japan Pneumonia Vaccine Sales Share by Company (2016-2021)
Table 48. Japan Pneumonia Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Pneumonia Vaccine Revenue Share by Company (2016-2021)
Table 50. Japan Pneumonia Vaccine Sales (K Doses) by Type (2016-2021)
Table 51. Japan Pneumonia Vaccine Sales Share by Type (2016-2021)
Table 52. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Pneumonia Vaccine Price (USD/Dose) by Type (2016-2021)
Table 54. Japan Pneumonia Vaccine Sales (K Doses) by Type (2022-2027)
Table 55. Japan Pneumonia Vaccine Sales Share by Type (2022-2027)
Table 56. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Pneumonia Vaccine Revenue Share by Type (2022-2027)
Table 58. Japan Pneumonia Vaccine Price (USD/Dose) by Type (2022-2027)
Table 59. Japan Pneumonia Vaccine Sales (K Doses) by Application (2016-2021)
Table 60. Japan Pneumonia Vaccine Sales Share by Application (2016-2021)
Table 61. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Pneumonia Vaccine Price (USD/Dose) by Application (2016-2021)
Table 63. Japan Pneumonia Vaccine Sales (K Doses) by Application (2022-2027)
Table 64. Japan Pneumonia Vaccine Sales Share by Application (2022-2027)
Table 65. Japan Pneumonia Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Pneumonia Vaccine Revenue Share by Application (2022-2027)
Table 67. Japan Pneumonia Vaccine Price (USD/Dose) by Application (2022-2027)
Table 68. North America Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 69. North America Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Pneumonia Vaccine Sales by Region (2016-2021) & (K Doses)
Table 73. Asia Pacific Pneumonia Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Pneumonia Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 77. Europe Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 81. Latin America Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Pneumonia Vaccine Sales by Country (2016-2021) & (K Doses)
Table 85. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Pneumonia Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Pneumonia Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Pfizer Inc. Corporation Information
Table 89. Pfizer Inc. Description and Business Overview
Table 90. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Pfizer Inc. Pneumonia Vaccine Product
Table 92. Pfizer Inc. Recent Development
Table 93. Glaxosmithkline Plc. Corporation Information
Table 94. Glaxosmithkline Plc. Description and Business Overview
Table 95. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Glaxosmithkline Plc. Product
Table 97. Glaxosmithkline Plc. Recent Development
Table 98. Merck & Co., Inc. Corporation Information
Table 99. Merck & Co., Inc. Description and Business Overview
Table 100. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Merck & Co., Inc. Product
Table 102. Merck & Co., Inc. Recent Development
Table 103. Sanofi Pasteur Corporation Information
Table 104. Sanofi Pasteur Description and Business Overview
Table 105. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Sanofi Pasteur Product
Table 107. Sanofi Pasteur Recent Development
Table 108. Serum Institute of India Pvt. Ltd. Corporation Information
Table 109. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 110. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Serum Institute of India Pvt. Ltd. Product
Table 112. Serum Institute of India Pvt. Ltd. Recent Development
Table 113. Johnson & Johnson Corporation Information
Table 114. Johnson & Johnson Description and Business Overview
Table 115. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Recent Development
Table 118. Astellas Pharma Inc. Corporation Information
Table 119. Astellas Pharma Inc. Description and Business Overview
Table 120. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Astellas Pharma Inc. Product
Table 122. Astellas Pharma Inc. Recent Development
Table 123. Astrazeneca Plc. Corporation Information
Table 124. Astrazeneca Plc. Description and Business Overview
Table 125. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Astrazeneca Plc. Product
Table 127. Astrazeneca Plc. Recent Development
Table 128. CSL Limited Corporation Information
Table 129. CSL Limited Description and Business Overview
Table 130. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. CSL Limited Product
Table 132. CSL Limited Recent Development
Table 133. Emergent Biosolutions Corporation Information
Table 134. Emergent Biosolutions Description and Business Overview
Table 135. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Emergent Biosolutions Product
Table 137. Emergent Biosolutions Recent Development
Table 138. Walvax Biotechnology Corporation Information
Table 139. Walvax Biotechnology Description and Business Overview
Table 140. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Walvax Biotechnology Product
Table 142. Walvax Biotechnology Recent Development
Table 143. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 144. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 145. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. Royal (Wuxi) Bio-Pharmaceutical Product
Table 147. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 148. Zhifei Biologic Corporation Information
Table 149. Zhifei Biologic Description and Business Overview
Table 150. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. Zhifei Biologic Product
Table 152. Zhifei Biologic Recent Development
Table 153. Pneumonia Vaccine Market Trends
Table 154. Pneumonia Vaccine Market Drivers
Table 155. Pneumonia Vaccine Market Challenges
Table 156. Pneumonia Vaccine Market Restraints
Table 157. Pneumonia Vaccine Customers List
Table 158. Pneumonia Vaccine Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumonia Vaccine Product Picture
Figure 2. Global Pneumonia Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Pneumococcal Conjugate Vaccine (PCV13) Product Picture
Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23) Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pneumonia Vaccine Sales Market Share by Application in 2020 & 2027
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Sepsis
Figure 10. Pneumonia Vaccine Report Years Considered
Figure 11. Global Pneumonia Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pneumonia Vaccine Market Size 2016-2027 (US$ Million)
Figure 13. Global Pneumonia Vaccine Sales 2016-2027 (K Doses)
Figure 14. Global Pneumonia Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Pneumonia Vaccine Sales Market Share by Region (2016-2021)
Figure 16. Global Pneumonia Vaccine Sales Market Share by Region in 2020
Figure 17. Global Pneumonia Vaccine Revenue Market Share by Region (2016-2021)
Figure 18. Global Pneumonia Vaccine Revenue Market Share by Region in 2020
Figure 19. Global Pneumonia Vaccine Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Pneumonia Vaccine Revenue in 2020
Figure 21. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Pneumonia Vaccine Sales Market Share by Type (2016-2021)
Figure 23. Global Pneumonia Vaccine Sales Market Share by Type in 2020
Figure 24. Global Pneumonia Vaccine Revenue Market Share by Type (2016-2021)
Figure 25. Global Pneumonia Vaccine Revenue Market Share by Type in 2020
Figure 26. Global Pneumonia Vaccine Sales Market Share by Application (2016-2021)
Figure 27. Global Pneumonia Vaccine Sales Market Share by Application in 2020
Figure 28. Global Pneumonia Vaccine Revenue Market Share by Application (2016-2021)
Figure 29. Global Pneumonia Vaccine Revenue Market Share by Application in 2020
Figure 30. Japan Pneumonia Vaccine Sales Growth Rate 2016-2027 (K Doses)
Figure 31. Japan Pneumonia Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Pneumonia Vaccine Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Pneumonia Vaccine Players Market Share by Revenue in Pneumonia Vaccine in 2020
Figure 34. Japan Pneumonia Vaccine Revenue Share by Type (2016-2021)
Figure 35. Japan Pneumonia Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Japan Pneumonia Vaccine Revenue Share by Application (2016-2021)
Figure 37. Japan Pneumonia Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Pneumonia Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 39. North America Pneumonia Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Pneumonia Vaccine Sales Market Share by Country in 2020
Figure 41. North America Pneumonia Vaccine Revenue Market Share by Country in 2020
Figure 42. U.S. Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 43. U.S. Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 45. Canada Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Pneumonia Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 47. Europe Pneumonia Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Pneumonia Vaccine Sales Market Share by Country in 2020
Figure 49. Europe Pneumonia Vaccine Revenue Market Share by Country in 2020
Figure 50. Germany Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 51. Germany Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 53. France Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 55. U.K. Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 57. Italy Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 59. Russia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Pneumonia Vaccine Sales Growth Rate 2016-2021 (K Doses)
Figure 61. Asia Pacific Pneumonia Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Pneumonia Vaccine Sales Market Share by Region in 2020
Figure 63. Asia Pacific Pneumonia Vaccine Revenue Market Share by Region in 2020
Figure 64. China Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 65. China Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 67. Japan Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 69. South Korea Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 71. India Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 73. Australia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 75. Taiwan Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 77. Indonesia Pneumonia Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Pneumonia Vaccine Sales Growth Rate (2016-2021) (K Doses)
Figure 79. Thailand

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs